Tech Sell-Off Weighs on Nasdaq as Energy and Health Care Provide Midday Cushion

Midday Market Momentum and Index Performance

As of midday on Tuesday, July 7, 2026, the U.S. stock market is exhibiting a notable divergence between growth-oriented technology shares and defensive value sectors. While the broader market is under pressure, the pain is felt most acutely in the tech-heavy indexes. The Invesco QQQ Trust (QQQ), which tracks the Nasdaq 100, is leading the decline with a significant drop of 1.72%. This downward pressure is also weighing on the State Street SPDR S&P 500 ETF Trust (SPY), which has retreated 0.46% during the session.

In contrast, the blue-chip heavy State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) is showing more resilience, down a more modest 0.38%. Small-cap stocks are also seeing selling pressure, with the iShares Russell 2000 ETF (IWM) falling 0.6%. The midday momentum suggests a "risk-off" sentiment regarding high-valuation tech, as investors rotate capital into sectors perceived as safer or more sensitive to the current commodity environment.

Sector Rotation and Commodity Moves

The internal dynamics of the market today reveal a sharp rotation. The technology sector is the primary laggard, with the State Street Technology Select Sector SPDR ETF (XLK) falling 2.15%. The weakness is even more pronounced in the semiconductor space; the VanEck Semiconductor ETF (SMH) has plunged 4.07%, driven by heavy selling in major chipmakers.

However, it is not a sea of red across the board. Investors are finding refuge in the State Street Health Care Select Sector SPDR ETF (XLV), which is up 1.7%, and the iShares U.S. Real Estate ETF (IYR), gaining 1.63%. Energy stocks are also providing a significant lift as crude oil prices surge. The United States Oil Fund, LP (USO) is up 2.47%, propelling the State Street Energy Select Sector SPDR ETF (XLE) to a 1.53% gain. This spike in energy costs may be contributing to the broader market unease regarding persistent inflationary pressures.

Major Stock News and Corporate Developments

The most dramatic story in the individual stock market today belongs to Crinetics Pharmaceuticals, Inc. (CRNX). The stock has skyrocketed by a staggering 98.9% on massive volume, following positive clinical developments that have caught the attention of the entire biotech sector. Other notable gainers include Bluejay Diagnostics, Inc. (BJDX), which has climbed 31.2%.

On the downside, the semiconductor giants are dragging the indexes lower. Micron Technology, Inc. (MU) is one of the most active stocks of the day, falling 6.2%. Industry bellwether Nvidia Corp (NVDA) is also trading in the red, down 1.6%, as the recent AI-driven rally faces a period of consolidation.

In the bond market, yields appear to be moving higher, putting pressure on fixed-income assets. The iShares 20+ Year Treasury Bond ETF (TLT) has dropped 0.71%, reflecting a shift in interest rate expectations as the market prepares for upcoming economic data.

Upcoming Market Events to Watch

Investors are looking ahead to the official start of the second-quarter earnings season later this week. On Thursday, July 9th, the market will receive key reports before the opening bell from PepsiCo, Inc. (PEP) and Delta Air Lines, Inc. (DAL). These results will provide crucial insights into consumer spending habits and the health of the travel industry.

The following week will see the traditional ramp-up of financial reporting. On Tuesday, July 14th, a wave of major banking institutions will report, including JPMorgan Chase & Co. (JPM), Bank of America Corporation (BAC), Goldman Sachs Group Inc. (GS), Wells Fargo & Co. (WFC), and Citigroup Inc. (C). These reports are expected to set the tone for the remainder of the summer trading session, particularly regarding net interest margins and the outlook for the broader economy.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Scroll to Top